Lonza - Capsugel®

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Clover and GSK Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with Pandemic Adjuvant System

Tuesday, February 25, 2020

Clover Biopharmaceuticals a China based global clinicalstage biotechnology company focused on developing novel and transformative biologic therapies announced today that it has entered into a research collaboration with GSK for its proteinbased coron...

Aradigm Announces Entering into an Asset Purchase Agreement with Grifols, S.A.

Saturday, February 22, 2020

Aradigm Corporation announced that the Company has entered into an Asset Purchase Agreement pursuant to which Grifols SA the Buyer will acquire the Companys assets and intellectual property that pertain to Lipoquin Free Ciprofloxacin Apulmiq and any...

Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial

Friday, February 21, 2020

Hummingbird Bioscience an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficulttotreat conditions today announced it has signed an agreement with Mycenax Biotech for the production of mate...

Immatics and GSK Partner to Develop Novel Adoptive Cell Therapies

Friday, February 21, 2020

Immatics Biotechnologies GmbH a clinicalstage biopharmaceutical company active in the discovery and development of Tcell redirecting cancer immunotherapies today announced it has entered into a strategic collaboration agreement with GSK to develop no...

Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs

Thursday, February 20, 2020

Five Prime Therapeutics Inc a clinicalstage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers today announced a global license agreement with Seattle Genetics Inc to develop and commercializ...

Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics

Thursday, February 20, 2020

Nimble Therapeutics Inc announced a multiyear collaboration with Genentech a member of the Roche Group to accelerate discovery and development of novel peptidebased medicines for targets across a range of diseases

M8 Pharmaceuticals and Vectans Pharma signed an exclusive licensing agreement of Loramyc® (miconazole Lauriad®) for Mexico and Brazil

Wednesday, February 19, 2020

M Pharmaceuticals and Vectans Pharma announced they have signed an exclusive licensing agreement whereby m will have the rights to register and commercialize Loramyc miconazole for Mexico and Brazil Loramyc is an antifungal agent administered as a mu...

EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19

Wednesday, February 19, 2020

EastGate Biotech Corp a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type diabetes announced today that the company along with its Joint Venture Partner EastG...

Novartis receives EC Approval for Beovu®, a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide

Tuesday, February 18, 2020

Novartis announced the European Commission EC has approved Beovu brolucizumab injection for the treatment of wet agerelated macular degeneration AMD Beovu is the first ECapproved antiVEGF treatment to demonstrate superior resolution of retinal fluid...

PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application

Monday, February 17, 2020

PharmaMar and Jazz Pharmaceuticals plc announce that the US Food and Drug Administration FDA accepted for filing with Priority Review the New Drug Application NDA seeking accelerated approval for lurbinectedin for the treatment of patients with Small...

MECO - 90 Years